Application of the ATLAS score for evaluating the severity of Clostridium difficile infection in teaching hospitals in Mexico

This publication has 12 references indexed in Scilit:

• Multistate Point-Prevalence Survey of Health Care–Associated Infections
  New England Journal of Medicine, 2014
• Derivation and validation of a simple clinical bedside score (ATLAS) for Clostridium difficile infection which predicts response to therapy
  BMC Infectious Diseases, 2013
• Fidaxomicin Versus Vancomycin for Clostridium difficile Infection: Meta-analysis of Pivotal Randomized Controlled Trials
  Clinical Infectious Diseases, 2012
• An Innovative Severity Score Index for Clostridium difficile Infection
  Infectious Diseases in Clinical Practice, 2011
• Fidaxomicin versus Vancomycin forClostridium difficileInfection
  New England Journal of Medicine, 2011
• National point prevalence of Clostridium difficile in US health care facility inpatients, 2008
  American Journal of Infection Control, 2009
• Clinical Risk Factors for SevereClostridium difficile–associated Disease
  Emerging Infectious Diseases, 2009
• Predictors of serious complications due to Clostridium difficile infection
  Alimentary Pharmacology & Therapeutics, 2009
• A Comparison of Vancomycin and Metronidazole for the Treatment of Clostridium difficile-Associated Diarrhea, Stratified by Disease Severity
  Clinical Infectious Diseases, 2007
• A Predominantly Clonal Multi-Institutional Outbreak ofClostridium difficile–Associated Diarrhea with High Morbidity and Mortality
  New England Journal of Medicine, 2005